Skip to main content
Premium Trial:

Request an Annual Quote

Firefly Bio Raises $775K, Eyeing $1.5M

NEW YORK (GenomeWeb) – Firefly BioWorks said in a document filed with the US Securities and Exchange Commission that it has raised $775,000 toward a targeted amount of $1.5 million.

The names of the investors or how the funds would be used were not disclosed. A spokesperson for Cambridge, Mass.-based miRNA assay firm declined to comment.

Firefly's portfolio includes the multiplexed Firefly Cellular microRNA Assay, which allows up to 68 small RNA targets of interest to be analyzed simultaneously. The assay is based on hydrogel particles and can be completed in approximately four hours, according to Firefly's website.

In the fall, Firefly signed a deal with EMD Millipore, a division of Germany's Merck KGaA, for the global distribution of Firefly's SmartRNAplex miRNA profiling assay.

The firm also has been developing the Firefly Circulating microRNA Assay, which detects up to 68 miRNA targets per sample in a 96-well format. The assay combines particle-based multiplexing with single-step RT-PCR signal amplification using universal primers. According to Firefly, the assay will be launching this summer.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.